High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s
Researchers have found that adults 65 and older who received a high-dose influenza vaccine had a significantly lower risk of developing Alzheimer’s disease compared to those who received the standard dose.
FDA Approves Gene Therapy for Rare Immune Disorder
FDA has approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe leukocyte adhesion deficiency type I.
IVIG Effective in Treating Infants with HDFN
A recent study has found intravenous immune globulin (IVIG) therapy in infants with hemolytic disease of the fetus and newborn (HDFN) found that it could be beneficial.
Airborne Spread of Flu Is Reduced by Targeting Two Flu Proteins
A new study demonstrates a way to stop the influenza virus from leaping from one host to the next while continuing to keep the virus from replicating inside the host.
AREXVY RSV Vaccine Approved for Expanded Age Indication
The U.S. Food and Drug Administration has expanded the approved age indication of AREXVY to adults aged 18 to 49 years at increased risk for lower respiratory tract disease caused by RSV.
IVIG Plus IVMP Does Not Increase Remission Rates in CIDP Patients
According to a recent study, adding intravenous methylprednisolone to intravenous immune globulin induction therapy does not significantly increase remission rates among patients with chronic inflammatory demyelinating polyradiculoneuropathy.
New Skin Patch More Accurately Monitors Immune Conditions
Researchers have developed a bandage-like microneedle patch that samples key cells often missed in routine blood samples and biopsies without the need for taking blood or surgical biopsies.
Researchers Discover Why a Rare Blood Clot Occurs After COVID-19 Vaccination
Researchers have discovered why the unusual side effect of a blood clot that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines occurred.
Scientists Develop a Potential Universal Respiratory Vaccine
Stanford Medicine researchers have invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens, which is the closest yet to a universal vaccine.
FDA Grants Breakthrough Designation for Wayrilz to Treat Autoimmune Hemolytic Anemia
The U.S. Food and Drug Administration has granted a designation as breakthrough therapy to Wayrilz (rilzabrutinib), a novel oral, reversible Bruton’s tyrosine kinase inhibitor, for the treatment of patients with warm autoimmune hemolytic anemia.